Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on

Lancet. 1990 Mar 3;335(8688):541. doi: 10.1016/0140-6736(90)90775-z.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cyclophosphamide / therapeutic use
  • Drug Evaluation
  • Female
  • Fluorouracil / therapeutic use
  • Humans
  • Menopause
  • Methotrexate / therapeutic use
  • Neoplasm Staging
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Tamoxifen / therapeutic use*

Substances

  • Tamoxifen
  • Cyclophosphamide
  • Fluorouracil
  • Methotrexate

Supplementary concepts

  • CMF regimen